Klinicki Centar Kragujevac
About Klinicki Centar Kragujevac
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Immunic AG
2
Clinical Trials at Klinicki Centar Kragujevac
During the past decade, Klinicki Centar Kragujevac conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Ulcerative Colitis
2019-12-19
2022-10-25
Completed
246
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
2020-12-16
2023-08-31
Active, not recruiting
6,522
Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years
2022-01-13
2027-12-09
Recruiting
110
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)
2021-06-07
2025-01-31
Recruiting
586
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
2021-08-14
2025-08-01
Enrolling by invitation
14,000
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
2021-09-30
2024-07-28
Recruiting
450
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
2022-01-12
2032-10-01
Recruiting
1,050
A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer
2023-01-09
2023-02-22
Terminated
6
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinicki Centar Kragujevac" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Immunic AG" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Aileron Therapeutics, Inc." with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinicki Centar Kragujevac"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Klinicki Centar Kragujevac
According to Clinical.Site data, the most researched conditions in "Klinicki Centar Kragujevac" are
"Acute Myocardial Infarction" (1 trials), "Esophagitis" (1 trials), "Moderate to Severe Ulcerative Colitis" (1 trials), "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Klinicki Centar Kragujevac" in a lesser frequency.
Clinical Trials Intervention Types at Klinicki Centar Kragujevac
Most popular intervention types in "Klinicki Centar Kragujevac" are "Drug" (7 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "0 mg Induction ONLY" (1 trials), "150 mg Induction/Chronic" (1 trials), "450 mg Induction/Chronic" (1 trials) and "50 mg Induction/Chronic" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinicki Centar Kragujevac
The vast majority of trials in "Klinicki Centar Kragujevac" are
8 trials for "All" genders.
Clinical Trials Status at Klinicki Centar Kragujevac
Currently, there are NaN active trials in "Klinicki Centar Kragujevac".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 1 completed trials in Klinicki Centar Kragujevac,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinicki Centar Kragujevac, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".